cpd image

CRM Trial Connect 2022

CRM Trial Connect 2022 is the first international conference organised by Clinical Research Malaysia, aimed to showcase Malaysia’s capabilities, experience and achievements in multinational clinical research, including sponsored clinical trials. Since CRM’s establishment in 2012, the organisation has been positioned as a one-stop centre for Sponsors and CROs to connect and engage with study sites and investigators in Malaysia.

We welcome interested parties to participate in this conference as it provides an excellent networking platform for clinical research industry players and investigators to explore new opportunities in clinical trial conduct in Malaysia.

Thank you to all our participants of CRM Trial Connect 2022!

Fast Facts:

  • 435 Delegates, Exhibitors & Faculty Members, 12 countries
  • 32 Presentations from 11 Sessions, 2 Forums, 2 Keynote Addresses

Participating Organisations:

  • Advaccine
  • AstraZeneca
  • Bayer
  • Beacon Hospital Dublin
  • Beacon Hospital Sdn Bhd
  • Beigene
  • Bio Molecular Industries Sdn. Bhd.: true;
  • Boehringer Ingelheim
  • Cancer CRI Centre
  • Cancer Research Malaysia
  • Careon Pharmacy
  • ClinData Consult Sdn Bhd
  • Clinical Research Malaysia
  • Columbia Asia Sdn Bhd
  • Crytomics Sdn Bhd
  • Drugs for Neglected Diseases (DNDi)
  • George Clinical
  • Harvard University
  • Healthy Malaysia Association
  • Hematogenix Sdn Bhd
  • Hospital Al-Sultan Abdullah UiTM (HASA UiTM)
  • Hospital Canselor Tuanku Muhriz
  • Hospital Kuala Lumpur
  • Hospital Melaka
  • Hospital Miri
  • Hospital Raja Permaisuri Bainun
  • Hospital Serdang
  • Hospital Seri Manjung, Perak
  • Hospital Sultan Abdul Halim
  • Hospital Tengku Ampuan Afzan
  • Hospital Tuanku Ja'afar Seremban
  • Hospital Tengku Ampuan Afzan
  • Hospital Pulau Pinang
  • ICON Plc
  • Info Kinetics Sdn Bhd
  • Innvocept Global Solutions
  • Institute for Clinical Research, NIH
  • Institute for Medical Research, NIH
  • Institute Jantung Negara
  • InterVenn (Venn Biosciences Sdn Bhd)
  • IQVIA RDS Malaysia Sdn Bhd
  • Johnson & Johnson Sdn Bhd
  • Klinik Kesihatan Seremban 2
  • Klinsel
  • M&B Healthcare Sdn Bhd
  • MAHSA University
  • Malaysia Genome and Vaccine Institute (MGVI)
  • Medical Device Authority (MDA)
  • MediqTrans
  • MedPharse Enterprise
  • MERCK Pte Ltd
  • Malaysian Investment Development Authority (MIDA)
  • Ministry of Health Malaysia
  • MiRXES
  • Malaysian Society for Stem Cell Research and Therapy (MSCRT)
  • Merck Sharp & Dohme
  • National Pharmaceutical Regulatory Agency, MOH
  • National Center for Global Health and Medicine, Japan
  • National Cancer Centre, Japan
  • Novartis
  • Novavax
  • Novo Nordisk
  • Novotech
  • Oxford University, UK
  • Pantai Hospital Kuala Lumpur
  • Pantai Premier Pathology
  • Parexel International (M) Sdn. Bhd.
  • Peli Bio Thermal, Singapore
  • Pfizer (Malaysia) Sdn Bhd
  • Pharmaceutical Association of Malaysia (phAMA)
  • PPD, part of Thermo Fisher Scientific
  • Prestige Biopharma Limited, Singapore
  • Prince Court Medical Centre
  • Princess Margeret Cancer Centre, Canada
  • Remedy & Company
  • Roche Malaysia Sdn Bhd
  • Sarawak General Hospital
  • Shanghai Fudan University, China
  • St Vincent's Hospital Melbourne, Australia
  • Subang Jaya Medical Centre
  • Sunway Medical Centre Sdn. Bhd.
  • Syneos Health
  • Taimei
  • Takeda
  • Tigermed
  • UCSI University, Kuala Lumpur Campus
  • University Kebangsaan Malaysia
  • University of Malaya
  • University of Malaya Medical Centre
  • Universiti Kuala Lumpur Royal College of Medicine Perak (UNIKL RCMP)
  • Universiti Malaysia Sabah
  • Universiti Sains Malaysia
  • Universiti Teknologi MARA
  • University of Cyberjaya
  • USMARI Research & Innovation Centre
  • Xeraya Capital
  • Yakin Splendour
  • Yokogawa
  • Zuellig Pharma

Program Details:

14 - 15

October 2022

Pullman KLCC

Kuala Lumpur, Malaysia

Accelerating Malaysia
in Global Clinical Trials

Who Should Attend?

Clinical Trial Sponsors, CROs, Investigators, Research Institutions & Clinical Research Stakeholders


Clinical Research Malaysia

Established by Malaysian Ministry of Health in 2012, Clinical Research Malaysia (CRM) exists to advance global health solutions for a brighter, more hopeful future for the people by providing speedy and reliable end-to-end clinical research support for quality studies.

Clinical Research Malaysia is ISO 9001:2015 (Quality Management System) & ISO 37001:2016 (Anti-Bribery Management System) certified organisation.For more information about CRM, do head to www.clinicalresearch.my

Platinum Sponsors

Gold Sponsors